Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 14, 2007

Harvard Medical School and Merck & Co. to Advance Cancer and CNS Research

  • Harvard Medical School’s (HMS) Office of Technology Development and Merck & Co. signed a cooperative research agreement under which the partners will jointly advance research programs in oncology and central nervous system disorders.

    Funding will be provided for six HMS labs. Scientists from HMS and Merck will work collaboratively in an effort to unify the program’s goals.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »